CompletedNot applicableNCT01931644

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Checked against the public recordLast updated Apr 18, 2024 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorSanguine Biosciences
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Sanguine Biosciences
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * All adults 18-100 years old * Able to provide proof of diagnosis * Live in USA Exclusion Criteria: * Younger than 18 years old * Receipt of blood products within 30 days of study blood collection * Receipt of investigational drug within 30 days of study blood collection

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Sanguine BiosciencesLos Angeles, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 18, 2024. Always confirm current availability with the study team.

View original record ↗